Pieris Pharmaceuticals Inc (PIRS)
15.93
-0.08
(-0.47%)
USD |
NASDAQ |
Nov 21, 16:00
15.93
0.00 (0.00%)
After-Hours: 20:00
Pieris Pharmaceuticals Market Cap: 21.04M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 21.04M |
| November 20, 2024 | 21.14M |
| November 19, 2024 | 20.58M |
| November 18, 2024 | 20.38M |
| November 15, 2024 | 20.95M |
| November 14, 2024 | 21.06M |
| November 13, 2024 | 21.26M |
| November 12, 2024 | 21.28M |
| November 11, 2024 | 21.08M |
| November 08, 2024 | 22.29M |
| November 07, 2024 | 21.82M |
| November 06, 2024 | 22.12M |
| November 05, 2024 | 22.51M |
| November 04, 2024 | 22.49M |
| November 01, 2024 | 22.91M |
| October 31, 2024 | 22.77M |
| October 30, 2024 | 22.27M |
| October 29, 2024 | 22.44M |
| October 28, 2024 | 22.44M |
| October 25, 2024 | 22.36M |
| October 24, 2024 | 22.44M |
| October 23, 2024 | 22.38M |
| October 22, 2024 | 21.68M |
| October 21, 2024 | 22.18M |
| October 18, 2024 | 22.34M |
| Date | Value |
|---|---|
| October 17, 2024 | 22.35M |
| October 16, 2024 | 21.77M |
| October 15, 2024 | 21.45M |
| October 14, 2024 | 21.48M |
| October 11, 2024 | 21.85M |
| October 10, 2024 | 21.59M |
| October 09, 2024 | 21.35M |
| October 08, 2024 | 21.18M |
| October 07, 2024 | 21.36M |
| October 04, 2024 | 21.47M |
| October 03, 2024 | 21.51M |
| October 02, 2024 | 21.85M |
| October 01, 2024 | 21.93M |
| September 30, 2024 | 21.89M |
| September 27, 2024 | 21.33M |
| September 26, 2024 | 21.33M |
| September 25, 2024 | 21.77M |
| September 24, 2024 | 22.54M |
| September 23, 2024 | 22.71M |
| September 20, 2024 | 22.76M |
| September 19, 2024 | 22.43M |
| September 18, 2024 | 21.33M |
| September 17, 2024 | 21.86M |
| September 16, 2024 | 21.92M |
| September 13, 2024 | 22.01M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
8.621M
Minimum
Jul 11 2024
390.27M
Maximum
Sep 17 2021
124.41M
Average
126.23M
Median
Market Cap Benchmarks
| Ligand Pharmaceuticals Inc | 2.202B |
| NovaBay Pharmaceuticals Inc | 3.517M |
| Palatin Technologies Inc | 18.35M |
| iBio Inc | 22.42M |
| Theriva Biologics Inc | 3.562M |
Market Cap Related Metrics
| PS Ratio | 0.4956 |
| Price to Book Value | 1.293 |
| Price | 15.93 |
| Earnings Yield | -76.38% |